Michael R. Braden, Ph.D.

Medicinal Chemistry and Molecular Pharmacology Purdue University, West Lafayette, IN, United States 
Dopamine and Serotonin Agonists
"Michael Braden"
Mean distance: 18.08 (cluster 11)


Sign in to add mentor
John J. Naleway grad student Purdue (Cell Biology Tree)
David E. Nichols grad student 2007 Purdue
 (Towards a biophysical understanding of hallucinogen action.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Braden MR, Nichols DE. (2007) Assessment of the roles of serines 5.43(239) and 5.46(242) for binding and potency of agonist ligands at the human serotonin 5-HT2A receptor. Molecular Pharmacology. 72: 1200-9
Braden MR, Parrish JC, Naylor JC, et al. (2006) Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Molecular Pharmacology. 70: 1956-64
McLean TH, Parrish JC, Braden MR, et al. (2006) 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists. Journal of Medicinal Chemistry. 49: 5794-803
McLean TH, Chambers JJ, Parrish JC, et al. (2006) C-(4,5,6-trimethoxyindan-1-yl)methanamine: a mescaline analogue designed using a homology model of the 5-HT2A receptor. Journal of Medicinal Chemistry. 49: 4269-74
Parrish JC, Braden MR, Gundy E, et al. (2005) Differential phospholipase C activation by phenylalkylamine serotonin 5-HT 2A receptor agonists. Journal of Neurochemistry. 95: 1575-84
See more...